Le produit a bien été ajouté au panier.

discount label
H-CCLCLTVFL-OH
Vue en 3D

Biosynth logo

H-CCLCLTVFL-OH

Ref. 3D-PP42861

1mg
217,00 €
10mg
253,00 €
100mg
455,00 €
Livraison estimée en/au États-Unis, le vendredi 27 décembre 2024

Informations sur le produit

Nom :
H-CCLCLTVFL-OH
Synonymes :
  • NH2-Cys-Cys-Leu-Cys-Leu-Thr-Val-Phe-Leu-OH
Description :

Peptide H-CCLCLTVFL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-CCLCLTVFL-OH include the following: in vivo and in vitro Anti-Tumor Efficiency by Tumor-Specific CD8+ CTL Induced with Tumor Associated Peptide Y Chu , Q HE - Chinese Journal of Cancer Biotherapy, 1996 - pesquisa.bvsalud.orghttps://pesquisa.bvsalud.org/portal/resource/pt/wpr-581746 Enhanced antitumoral effect of adenovirus-mediated cytosine deaminase gene therapy by induction of antigen-presenting cells through stem cell factor/granulocyte X Cao, X Huang, DW Ju, W Zhang, H Hamada - Cancer Gene , 2000 - nature.comhttps://www.nature.com/articles/7700114 Identification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney, and Rauscher murine leukemia virus-induced tumors W Chen, H Qin, B Chesebro, MA Cheever - Journal of virology, 1996 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.70.11.7773-7782.1996 Flow-Microfluorometric Monitoring of VEEI Vivo, CD Oligoclonal - J Immunol, 1998 - researchgate.nethttps://www.researchgate.net/profile/Giovanni-Biasi-2/publication/13762307_Flow-Microfluorometric_Monitoring_of_Oligoclonal_CD8_T_Cell_Responses_to_an_Immunodominant_Moloney_Leukemia_Virus-Encoded_Epitope_In_Vivo/links/0c96052234e88a7705000000/Flow-Microfluorometric-Monitoring-of-Oligoclonal-CD8-T-Cell-Responses-to-an-Immunodominant-Moloney-Leukemia-Virus-Encoded-Epitope-In-Vivo.pdf MicroRNA-150 modulates intracellular Ca2+ levels in naaca¯ve CD8+ T cells by targeting TMEM20 TD Kim , HR Jung, SH Seo, SC Oh , Y Ban , X Tan - Scientific reports, 2017 - nature.comhttps://www.nature.com/articles/s41598-017-02697-x Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants T van Hall , EZ Wolpert, P van Veelen, S Laban - Nature medicine, 2006 - nature.comhttps://www.nature.com/articles/nm1381 Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28 T van Hall , A Sijts , M Camps, R Offringa - The Journal of , 2000 - rupress.orghttps://rupress.org/jem/article-abstract/192/4/483/25927 Host-derived CD8+ dendritic cells are required for induction of optimal graft-versus-tumor responses after experimental allogeneic bone marrow transplantation T Toubai, Y Sun , G Luker , J Liu - Blood, The Journal , 2013 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/121/20/4231/116519 CD8+ T Cell Exhaustion During Persistent Viral Infection is Regulated Independently of the Virus-Specific T Cell Receptor SR Jackson, MM Berrien-Elliott , JM Meyer - Immunological , 2013 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.3109/08820139.2012.751397 Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor S Tahara-Hanaoka , K Shibuya , H Kai, A Miyamoto - Blood, 2006 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/107/4/1491/133712 Identification of a gag-encoded cytotoxic T-lymphcyte epitope from FBL3 leukemia virus-induced tumors Q Huilian, C Wei, C Yongliang - Zhongguo Mian yi xue za , 1997 - europepmc.orghttps://europepmc.org/article/cba/308126 Modification of One Epitope-Flanking Amino Acid Allows for the Induction of Friend Retrovirus-Specific CD8+ T Cells by Adenovirus-Based Immunization P Gödel, S Windmann, KK Dietze, U Dittmer - Journal of , 2012 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.01607-12 Hierarchal Utilization of Different T-Cell Receptor Vbeta Gene Segments in the CD8+-T-Cell Response to an Immunodominant Moloney Leukemia Virus-Encoded P Brawand, JC Cerottini, HR MacDonald - Journal of virology, 1999 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.73.11.9161-9169.1999 Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo P Brawand, G Biasi, C Horvath, JC Cerottini - The Journal of , 1998 - journals.aai.orghttps://journals.aai.org/jimmunol/article/160/4/1659/924 Transgenic expression of Ly49A on T cells impairs a specific antitumor response P Brawand, FA Lemonnier, HR MacDonald - The Journal of , 2000 - journals.aai.orghttps://journals.aai.org/jimmunol/article/165/4/1871/69723 Checkpoint Blockade Immunotherapy Relies on T-bet but Not Eomes to Induce Effector Function in Tumor-Infiltrating CD8+ T Cells MM Berrien-Elliott , J Yuan , LE Swier, SR Jackson - Cancer immunology , 2015 - AACRhttps://aacrjournals.org/cancerimmunolres/article-abstract/3/2/116/467709 Generation and expression of high affinity, tumor antigen-specific mouse and human T cell receptors to genetically modify CD8 (+) T cells for adoptive ML Dossett - 2006 - search.proquest.comhttps://search.proquest.com/openview/e15a6c0fb38ba9554ef38793b6bb4bcb/1?pq-origsite=gscholar&cbl=18750&diss=y Therapy with cultured T cells: principles revisited MA Cheever, W Chen - Immunological reviews, 1997 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1600-065X.1997.tb00982.x Effective immunotherapy of cancer in MUC1-transgenic mice using clonal cytotoxic T lymphocytes directed against an immunodominant MUC1 epitope LC Heukamp, T van Hall , F Ossendorp - Journal of , 2002 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2002/01000/effective_immunotherapy_of_cancer_in.5.aspx tumor protection induced by a cellular vaccine carrying a tumor-specific T helper epitope by genetic exchange of the class II-associated invariant chain peptide J van Bergen, M Camps, R Offringa, CJM Melief - Cancer research, 2000 - AACRhttps://aacrjournals.org/cancerres/article-abstract/60/22/6427/506896 DNA fusion gene vaccination mobilizes effective anti-leukemic cytotoxic T lymphocytes from a tolerized repertoire J Rice, ML Dossett, C aca–hlen, SL Buchan - European journal of , 2008 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200838213 Diverse Immunomodulatory Effects of Individual IFNalpha Subtypes on Virus-Specific CD8+ T Cell Responses J Dickow, S Francois, RL Kaiserling - Frontiers in , 2019 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2019.02255/full Overlapping epitopes of Friend murine leukemia virus gag-encoded leader sequence recognized by single cytotoxic T-lymphocyte clones H Uenishi, N Iwanami , K Kuribayashi, H Tamamura - Immunology letters, 1998 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0165247898000200 Retroviral infection in vivo requires an immune escape virulence factor encrypted in the envelope protein of oncoretroviruses G Schlecht-Louf , M Renard - Proceedings of the , 2010 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.0913122107 Dissecting the immune response to Moloney murine sarcoma/leukemia virus-induced tumors by means of a DNA vaccination approach G Milan, A Zambon, M Cavinato, P Zanovello - Journal of , 1999 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.73.3.2280-2287.1999 Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors F Ossendorp , E Mengede, M Camps, R Filius - The Journal of , 1998 - rupress.orghttps://rupress.org/jem/article-abstract/187/5/693/7454 Comparative evaluation of the vaccine efficacies of three adenovirus-based vector types in the Friend retrovirus infection model CP Hrycak, S Windmann, W Bayer - Journal of Virology, 2019 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.01155-19 in vivo and in vitro Anti-Tumor Efficiency by Tumor-Specific CD8+ CTL Induced with Tumor Associated Peptide CHU Yiwei , HE Qiuzao - Chinese Journal of Cancer , 1996 - pesquisa.bvsalud.orghttps://pesquisa.bvsalud.org/gim/resource/ru/wpr-581746 Peptide transporter TAP mediates between competing antigen sources generating distinct surface MHC class I peptide repertoires CC Oliveira, B Querido, M Sluijter - European journal of , 2011 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.201141836 A large number of T lymphocytes recognize Moloney-murine leukemia virus-induced antigens, but a few mediate long-lasting tumor immunosurveillance A Facchinetti, SD Santa, S Mezzalira - The Journal of , 2005 - journals.aai.orghttps://journals.aai.org/jimmunol/article/174/9/5398/72500

Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :

Propriétés chimiques

MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :

Informations sur les risques

Numéro ONU :
EQ:
Classe :
Phrases R :
Phrases S :
Transport aérien interdit :
Informations sur les risques :
Groupe d'emballage :
LQ :

Question d’ordre technique sur : 3D-PP42861 H-CCLCLTVFL-OH

Veuillez plutôt utiliser le panier afin de demander un devis ou passer commande

Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages

* Champ obligatoire
Bienvenue chez CymitQuimica !Nous utilisons des cookies pour améliorer votre visite. Nous n’incluons pas de publicité.

Veuillez consulter notre Politique de Cookies pour plus de détails ou ajustez vos préférences dans "Configurer".